发明名称 Intraocular Formulation
摘要 Biodegradable therapeutic agent incorporating microspheres formulated in a high viscosity carrier suitable for intraocular administration to treat an ocular condition. The formulation can also be used to treat non-ocular conditions such as articular pathologies
申请公布号 US2015147406(A1) 申请公布日期 2015.05.28
申请号 US201414298418 申请日期 2014.06.06
申请人 Allergan, Inc. 发明人 Robinson Michael R.;Blanda Wendy M.;Liu Hui;Whitcup Scott M.;Hughes Patrick M.
分类号 A61K9/16;A61K9/00;A61K47/36;A61K31/573;C07K16/22 主分类号 A61K9/16
代理机构 代理人
主权项 1. A biocompatible, injectable intraocular drug delivery system comprising: (a) a plurality of biodegradable microspheres; (b) a therapeutic agent incorporated by the microspheres; and (c) a viscous carrier for the microspheres, the viscous carrier having a viscosity at 25° C. of between about 140,000 cps and about 500,000 cps at a shear rate of 0.1/second, thereby forming a biocompatible, injectable intraocular drug delivery system, wherein the viscous carrier is a partially crosslinked hyaluronic acid, and wherein the microspheres comprise a poly(lactide-co-glycolide) (PLGA) polymer, the drug delivery system such that about one hour after intravitreal injection of the drug delivery system about 5% or less of the microspheres are present in the vitreous free of the viscous carrier.
地址 Irvine CA US
您可能感兴趣的专利